scholarly journals The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation

2012 ◽  
Vol 27 (7) ◽  
pp. 2010-2019 ◽  
Author(s):  
M. Mariani ◽  
P. Vigano ◽  
D. Gentilini ◽  
B. Camisa ◽  
E. Caporizzo ◽  
...  
Keyword(s):  
Vitamin D ◽  
Mouse Model ◽  
Vitamin D Receptor ◽  
Receptor Agonist ◽  
Peritoneal Inflammation

scholarly journals EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer

2005 ◽  
Vol 229 (2) ◽  
pp. 205-215 ◽  
Author(s):  
Erin L. Milliken ◽  
Xiaoxue Zhang ◽  
Chris Flask ◽  
Jeffrey L. Duerk ◽  
Paul N. MacDonald ◽  
...  
Keyword(s):  
Vitamin D ◽  
Growth Rate ◽  
Mouse Model ◽  
Tumor Growth ◽  
Vitamin D Receptor ◽  
Receptor Agonist ◽  
Mammary Cancer ◽  
Tumor Growth Rate

scholarly journals Carborane-based design of a potent vitamin D receptor agonist

2016 ◽  
Vol 7 (2) ◽  
pp. 1033-1037 ◽  
Author(s):  
Rocio Otero ◽  
Samuel Seoane ◽  
Rita Sigüeiro ◽  
Anna Y. Belorusova ◽  
Miguel A. Maestro ◽  
...  
Keyword(s):  
Vitamin D ◽  
Vitamin D Receptor ◽  
Receptor Agonist ◽  
Side Chain ◽  
Vitamin D Analog ◽  
Dihydrogen Bonding

The development of a promising clinical antitumor vitamin D analog possessing a side-chain o-carborane cluster that efficiently binds to VDR by unconventional dihydrogen bonding (BH⋯HN) is described.

Sign in / Sign up

Export Citation Format

Share Document